BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34634970)

  • 1. Risk Factors and Comorbidities Associated with Diabetic Kidney Disease.
    Roy S; Schweiker-Kahn O; Jafry B; Masel-Miller R; Raju RS; O'Neill LMO; Correia CR; Trivedi A; Johnson C; Pilot C; Saddemi J; Memon A; Chen A; McHugh SP; Patel S; Daroshefski NM; Nguyen T; Wissler W; Sharma E; Hunter K
    J Prim Care Community Health; 2021; 12():21501327211048556. PubMed ID: 34634970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.
    González-Pérez A; Saéz ME; Vizcaya D; Lind M; García Rodríguez LA
    Prim Care Diabetes; 2020 Aug; 14(4):381-387. PubMed ID: 31791904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.
    González-Pérez A; Saez M; Vizcaya D; Lind M; Garcia Rodriguez L
    BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34607828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological characteristics of diabetic kidney disease in Taiwan.
    Wang JS; Yen FS; Lin KD; Shin SJ; Hsu YH; Hsu CC;
    J Diabetes Investig; 2021 Dec; 12(12):2112-2123. PubMed ID: 34529360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of histopathological and clinical spectrum of diabetic kidney disease based on an unsupervised hierarchical clustering analysis of elderly autopsy specimens.
    Sugimoto H; Yumura W; Yamaguchi Y; Yamanaka N; Hashimoto S; Arai M; Matsuno S; Shimizu A; Arai T; Itabashi M; Takei T
    Nephrology (Carlton); 2022 Aug; 27(8):701-711. PubMed ID: 35436030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic Kidney Disease 3rd stage - laboratory markers of mineral bone disorder].
    Klimentová A; Ságová I; Prídavková D; Kantárová D; Makovický P; Sadloňová J; Mokáň M
    Vnitr Lek; 2016; 62(6):442-8. PubMed ID: 27485841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between morphological characteristics of retinal microvessels and diabetic kidney disease in patients with type 2 diabetes mellitus based on a machine learning model].
    Yang XK; Liu ZS; Li GP; Duan JY; Liu DW
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1393-1400. PubMed ID: 37150692
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021.
    Zeng YQ; Yang YX; Guan CJ; Guo ZW; Li B; Yu HY; Chen RX; Tang YQ; Yan R
    BMC Endocr Disord; 2022 Jun; 22(1):168. PubMed ID: 35773653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.
    Mccafferty K; Caplin B; Knight S; Hockings P; Wheeler D; Fan SL; Hulthe J; Kleta R; Ashman N; Papastefanou V; Mehta H; Salama A; Hadzovic S; Chowdhury TA; Jarl L; Unwin R; Challis B; Sundgren AK; Yaqoob MM
    BMJ Open; 2020 Sep; 10(9):e033923. PubMed ID: 32912939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of diabetic kidney disease and the associated factors among patients with type 2 diabetes in a multi-ethnic Asian country.
    Wan KS; Hairi NN; Mustapha F; Mohd Yusoff MF; Mat Rifin H; Ismail M; Moy FM; Ahmad NA
    Sci Rep; 2024 Mar; 14(1):7074. PubMed ID: 38528132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai.
    Liu W; Du J; Ge X; Jiang X; Peng W; Zhao N; Shen L; Xia L; Hu F; Huang S
    BMJ Open; 2022 Jun; 12(6):e060238. PubMed ID: 35768116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ELMO1 gene polymorphisms and diabetic kidney disease: A systematic review and meta-analysis.
    Azarboo A; Hosseinkhani S; Ghaseminejad-Raeini A; Aazami H; Mohammadi SM; Zeidi S; Razi F; Bandarian F
    PLoS One; 2024; 19(1):e0295607. PubMed ID: 38277369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for death and their predictive value on diabetic kidney disease patients in intensive care unit based on MIMIC-III database].
    Zhang S; Sun R; Mao Z; Yang H; Liu D; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1085-1090. PubMed ID: 33081895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
    Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
    Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic kidney disease: a report from an ADA Consensus Conference.
    Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
    Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.
    Chao CT; Wang J; Huang JW; Chan DC; Hung KY; Chien KL;
    Osteoporos Int; 2020 Apr; 31(4):699-708. PubMed ID: 32103279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.